Extracardiac Progenitor Cells Repopulate Most Major Cell Types in the Transplanted Human Heart

Background— Extracardiac progenitor cells are capable of repopulating cardiomyocytes at very low levels in the human heart after injury. Here, we explored the extent of endothelial, smooth muscle, and Schwann cell chimerism in patients with sex-mismatched (female-to-male) heart transplants. Methods and Results— Autopsy specimens from 5 patients and endomyocardial biopsies from 7 patients were used for this study. Endothelial, vascular smooth muscle, and Schwann cells were stained with antibodies against CD31 or Ulex europaeus lectin, smooth muscle α-actin, and S-100, respectively, and the Y chromosome was identified with in situ hybridization. Biopsy specimens from 1, 4, 6, and 12 months and 5 and 10 years after heart transplantation were evaluated. Y-positive cells were counted by conventional bright-field microscopy and confirmed by confocal microscopy. Endothelial cells showed the highest degree of chimerism, averaging 24.3±8.2% from extracardiac sources. Schwann cells showed the next highest chimerism, averaging 11.2±2.1%; vascular smooth muscle cells averaged 3.4±1.8%. All 3 cell types showed substantially higher chimerism than we previously observed for cardiomyocytes (0.04±0.05%). Endothelial chimerism was much higher in the microcirculation than in larger vessels. Analysis of serial endomyocardial biopsies revealed that high levels of endothelial chimerism occurred as early as 1 month after transplantation (22±6.6%) with no significant increases even up to 10 years after cardiac transplantation. Conclusions— Extracardiac progenitor cells are capable of repopulating most major cell types in the heart, but they do so with varying frequency. The signals for endothelial progenitor recruitment occur early and could relate to injury during allograft harvest or transplantation. The high degree of endothelial chimerism may have immune implications such as for myocardial rejection or graft vasculopathy.

[1]  D. Cramer,et al.  Pretransplant injection of allograft recipients with donor blood or lymphocytes permits allograft tolerance without the presence of persistent donor microchimerism. , 1996, Transplantation.

[2]  Arjun Deb,et al.  Endothelial Progenitor Cells Are Decreased in Blood of Cardiac Allograft Patients With Vasculopathy and Endothelial Cells of Noncardiac Origin Are Enriched in Transplant Atherosclerosis , 2003, Circulation.

[3]  M. Pfeffer,et al.  Ventricular enlargement and reduced survival after myocardial infarction. , 1987, Circulation.

[4]  M. Makuuchi,et al.  Circulating smooth muscle progenitor cells contribute to atherosclerosis , 2001, Nature Medicine.

[5]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[6]  C. Vogelmeier,et al.  Functional significance of cardiac reinnervation in heart transplant recipients. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  R. Colvin,et al.  Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys1 , 2002, Transplantation.

[8]  W. Edwards,et al.  Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Saffitz,et al.  Extracardiac Progenitor Cells Repopulate Most Major Cell Types in the Transplanted Human Heart , 2005, Circulation.

[10]  J. Travis Structure, function, and control of neutrophil proteinases , 1988 .

[11]  Erwin Hauser,et al.  Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice , 1999, Anatomy and Embryology.

[12]  G. Tenderich,et al.  Cellular repopulation of myocardial infarction in patients with sex-mismatched heart transplantation. , 2004, European heart journal.

[13]  W Grossman,et al.  Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. , 1986, Circulation.

[14]  M. Makuuchi,et al.  Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis , 2002, Nature Medicine.

[15]  J. Saffitz,et al.  Evidence for Cardiomyocyte Repopulation by Extracardiac Progenitors in Transplanted Human Hearts , 2002, Circulation research.

[16]  L. Hartley,et al.  Long-term sequential changes in exercise capacity and chronotropic responsiveness after cardiac transplantation. , 1997, Circulation.

[17]  D. Shum-Tim,et al.  The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. , 2001, The Journal of thoracic and cardiovascular surgery.

[18]  J. Lemons,et al.  PERIPHERAL BLOOD CHIMERISM IN RENAL ALLOGRAFT RECIPIENTS TRANSFUSED WITH DONOR BONE MARROW1,2 , 1994, Transplantation.

[19]  P. Georgii‐Hemming,et al.  Tolerance induction ameliorates allograft vasculopathy in rat aortic transplants. Influence of Fas-mediated apoptosis. , 1998, The Journal of clinical investigation.

[20]  C. Poremba,et al.  Evaluation of host stem cell-derived cardiac myocytes in consecutive biopsies in long-term cardiac transplant patients. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[21]  M. Orloff,et al.  Prevention Of Chronic Rejection And Graft Arteriosclerosis By Tolerance Induction , 1995, Transplantation.

[22]  R. Kloner,et al.  Early and late remodeling of the left ventricle after acute myocardial infarction. , 1984, The American journal of cardiology.

[23]  J. Rabkin,et al.  Tolerance induced by bone marrow chimerism prevents transplant vascular sclerosis in a rat model of small bowel transplant chronic rejection. , 2000, Transplantation.

[24]  D. Zimmer,et al.  The S100 protein family: History, function, and expression , 1995, Brain Research Bulletin.

[25]  M. Pfeffer,et al.  Angiotensin converting enzyme inhibition and ventricular remodeling in heart failure. , 1988, The American journal of medicine.

[26]  B. Díaz-Esnal,et al.  S‐100 proteins in the human peripheral nervous system , 2003, Microscopy research and technique.

[27]  S. Nekolla,et al.  Effect of sympathetic reinnervation on cardiac performance after heart transplantation. , 2001, The New England journal of medicine.

[28]  W. Baumgartner,et al.  Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation. , 1993, The American journal of pathology.

[29]  J. Epstein,et al.  Smooth Muscle Cells, But Not Myocytes, of Host Origin in Transplanted Human Hearts , 2002, Circulation.

[30]  G. Spangrude,et al.  Chimerism of the transplanted heart. , 2002, The New England journal of medicine.

[31]  Arjun Deb,et al.  Bone Marrow–Derived Cardiomyocytes Are Present in Adult Human Heart: A Study of Gender-Mismatched Bone Marrow Transplantation Patients , 2003, Circulation.

[32]  M. Entman,et al.  Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. , 2001, The Journal of clinical investigation.

[33]  E. Popa,et al.  Recipient origin of neointimal vascular smooth muscle cells in cardiac allografts with transplant arteriosclerosis. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[34]  T. Hirose,et al.  Malignant peripheral nerve sheath tumor of small round cell type with pleomorphic spindle cell sarcomatous areas , 2003, Pathology international.

[35]  J S Hochman,et al.  Expansion of acute myocardial infarction: an experimental study. , 1982, Circulation.

[36]  N. Morrissey,et al.  Induction of specific tolerance through mixed hematopoietic chimerism prevents chronic renal allograft rejection in a rat model. , 1996, Surgery.

[37]  R. Wilson,et al.  Chest pain in cardiac-transplant recipients. Evidence of sensory reinnervation after cardiac transplantation. , 1991, The New England journal of medicine.

[38]  J. Hillebrands,et al.  Origin of vascular smooth muscle cells and the role of circulating stem cells in transplant arteriosclerosis. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[39]  R. Cardinal,et al.  The heart reinnervates after transplantation. , 2000, The Annals of thoracic surgery.